Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SonoVue-Enhanced Ultrasound for Focal Liver Lesions
NCT00829413Phase 3Completed
- Sponsor
- Bracco Diagnostics Inc.
- Start
- Jun 2010
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sulfur hexafluoride in liver neoplasms, sponsored by Bracco Diagnostics Inc.. Started Jun 2010; status: completed.
02
Drugs
sulfur hexafluoride
03
Conditions
liver neoplasms
Beyond the preview
Go deeper on NCT00829413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00829413.